Faisal Khurshid Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Faisal Khurshid

Stock Analyst at Leerink Partners

(4.65)
# 1377
Out of 5,506 analysts
26
Total ratings
Success rate
Average return

21 Stocks

Name Action PT Current % Upside Ratings Updated
CTNM Contineum Therapeuti...
Initiates Coverage On: Outperform
20
11.35 76.21% 1 Sep 25, 2025
PTGX Protagonist Therapeu...
Initiates Coverage On: Outperform
73
64.83 12.6% 1 Sep 12, 2025
STTK Shattuck Labs
Maintains: Outperform
4 2
2.35 -14.89% 2 Aug 14, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Outperform
88 102
99.02 3.01% 2 Jul 10, 2025
ABCL AbCellera Biologics
Assumes: Outperform
5
5.9 -15.25% 1 Jul 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
3 1
1.55 -35.48% 2 Apr 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
15.89 183.2% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
16
9.38 70.58% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33 2
1.52 31.58% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
0.78 1951.28% 1 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 60
57.9 3.63% 2 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
89.64 -10.75% 1 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
3.93 281.68% 1 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
7
9.88 -29.15% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
45
19 136.84% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
24
37.62 -36.2% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
7
1.35 418.52% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
8
5.76 38.89% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
5
0.98 410.2% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
17 21
n/a n/a 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
11
4.63 137.58% 1 Mar 21, 2023